Edema
Basics
Basics
Basics
Description
Description
Description
- Clinically apparent accumulation of excess fluid in the interstitial compartment due to imbalances in capillary oncotic and hydrostatic drainage:
- Increase in venous/capillary hydrostatic pressure
- Decrease in plasma oncotic pressure
- Increase in interstitial oncotic pressure
- Increase in capillary permeability
- Increase in lymphatic pressure due to obstruction
- Combination of these factors
- Generalized, as with CHF or nephrotic syndrome
- Localized, as with deep vein thrombosis
- Increased venous hydrostatic pressure or decreased oncotic pressure results in pitting edema
- Protein-rich extravasated fluid results in nonpitting edema
- In certain disorders, there is no clear relation to Starling forces:
- Idiopathic (cyclic) edema:
- Worsened with heat
- More common in women
- Not necessarily related to menses
- Inflammatory states (burns, sepsis, allergic reactions) cause capillary leakage due to cytokine-mediated changes
- Lymphedema: Protein-rich fluid accumulation due to impaired lymphatic drainage
- Conditions like heart failure, cirrhosis, and nephrotic syndrome activate the renin–angiotensin–aldosterone system (RAAS), leading to sodium retention and exacerbating edema
- Peripheral edema is common, affecting up to 20% of adults over 50
- More common in older adults, particularly women with chronic venous insufficiency or lymphedema
Etiology
Etiology
Etiology
Generalized/Bilateral
Generalized/Bilateral
Generalized/Bilateral
- Heart failure
- Cor pulmonale
- Cardiomyopathies
- Constrictive pericarditis
- Pulmonary HTN:
- Renal disease/primary renal sodium retention
- Pregnancy/preeclampsia
- Sodium or fluid overload
- Proximal venous obstruction (eg, IVC syndrome)
Localized
Localized
Localized
- Venous obstruction or insufficiency
- Venous thrombosis (eg, DVT)
- Venous compression (eg, May–Thurner/iliac vein compression)
- Postthrombotic syndrome
- Baker cyst
- Hemiplegia
Decreased Plasma Oncotic Pressure
Decreased Plasma Oncotic Pressure
Decreased Plasma Oncotic Pressure
- Nephrotic syndrome
- Cirrhosis
- Protein-losing enteropathy/malabsorption
- Starvation/Kwashiorkor
- Preeclampsia
Generalized Increased Capillary Permeability
Generalized Increased Capillary Permeability
Generalized Increased Capillary Permeability
- Capillary leak syndrome (Clarkson disease)
- Sepsis/toxic shock
- Medications (gemcitabine, some interleukins and monoclonal antibodies)
Localized Increased Capillary Permeability
Localized Increased Capillary Permeability
Localized Increased Capillary Permeability
- Vasculitis
- Chronic lymphangitis
- Cellulitis
- Complex regional pain syndrome/reflex sympathetic dystrophy
- Ruptured Baker cyst
- Angioedema:
- Mechanical trauma
- Thermal injuries
- Radiation injuries
- Chemical burns
Increased Interstitial Oncotic Pressure
Increased Interstitial Oncotic Pressure
Increased Interstitial Oncotic Pressure
Increased Lymphatic Pressure
Increased Lymphatic Pressure
Increased Lymphatic Pressure
- Compressive or invasive tumor
- Postsurgical resection of lymphatics
- Postirradiation
- Complex regional pain syndrome/reflex sympathetic dystrophy
- Filariasis
Medications (By Primary Renal Sodium Retention, Vasodilation, Other Mechanisms)
Medications (By Primary Renal Sodium Retention, Vasodilation, Other Mechanisms)
Medications (By Primary Renal Sodium Retention, Vasodilation, Other Mechanisms)
- Antihypertensives (calcium channel blockers, β-blockers)
- Vasodilators:
- Hydralazine
- Minoxidil
- Sympathetic blockers
- Clonidine
- Guanethidine
- Methyldopa
- Hormones/endocrine therapy:
- Corticosteroids
- Estrogen, progesterone, testosterone
- Growth hormone
- GnRH agonists
- Anticancer drugs:
- Taxanes/docetaxel
- Tamoxifen
- Gemcitabine
- Pemetrexed
- Lenalidomide/thalidomide
- Targeted immunotherapy
- Immunosuppressants:
- Cyclosporine
- Tacrolimus
- mTOR inhibitors (Sirolimus, everolimus)
- Cytokines:
- Antipsychotics:
- Clozapine
- Olanzapine
- Quetiapine
- Risperidone
- Antidepressants:
- Escitalopram
- Mirtazapine
- Paroxetine
- Venlafaxine
- MAOIs
- Gabapentinoids:
- Antiepileptics:
- Parkinson meds/dopamine agonists:
- Pramipexole
- Ropinirole
- MAO-B inhibitors
- NSAIDs
- Thiazolidinediones/glitazones
- Insulin
- Baclofen
- Lithium
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2026 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.